Artemis Medicare Services Ltd

Artemis Medicare Services Ltd has announced its Board of Directors has recommended a final dividend of ₹0.45 per equity share for FY 2025-26. This dividend is subject to shareholder approval at the 22nd Annual General Meeting. The company has also provided detailed information regarding Tax Deduction at Source (TDS) or withholding tax applicable to dividend payments for FY 2025-26, outlining different rates and documentation requirements for resident and non-resident shareholders. The record date for dividend entitlement is July 10, 2026, and the dividend will be paid within 30 days of the AGM if approved.

Artemis Medicare Services Ltd has announced July 10, 2026, as the record date for its final dividend. The dividend, if approved by shareholders at the 22nd AGM on July 31, 2026, will be ₹0.45 per equity share (45% of face value Re. 1). This dividend is for the financial year 2025-26 and will be paid within 30 days of the AGM. The AGM will be conducted via video conferencing. The company has also outlined cut-off dates for AGM notice distribution and e-voting.

Artemis Medicare Services Ltd has announced its 22nd Annual General Meeting (AGM) will be held on July 31, 2026, via Video Conferencing. The company has fixed July 10, 2026, as the Record Date for its proposed final dividend of Re. 0.45 per equity share (45%) for FY 2025-26, subject to shareholder approval at the AGM. Key dates for shareholder voting and notice distribution have also been outlined.

Artemis Medicare Services Ltd. announced that Mr. Sunil Tandon (DIN: 08342585) has ceased to be a Director of the Company, effective May 9, 2026, upon completion of his tenure as an Independent Director. This disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Artemis Medicare Services Ltd has released the Monitoring Agency Report for the quarter ended March 31, 2026, as per Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 162A of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report, issued by CARE Ratings Limited, pertains to the utilization of proceeds from a Preferential Issue and was reviewed by the Audit Committee on May 8, 2026. The report indicates no deviations from the objects of the issue.

Artemis Medicare Services Ltd has amended its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. The amended code was approved by the Board of Directors on May 8, 2026, and is effective from February 4, 2019, with the last amendment made on the aforementioned date. The code aims to ensure timely and adequate disclosure of UPSI and maintain transparency in dealing with stakeholders.

The Board of Directors of Artemis Medicare Services Ltd, in its meeting on May 8, 2026, recommended a final dividend of Re. 0.45 per equity share (45%) for the financial year ended March 31, 2026, subject to shareholder approval at the upcoming AGM. The dividend will be paid within 30 days from the conclusion of the AGM. The board also approved the audited financial results for the quarter and year ended March 31, 2026, and appointed Mr. Tapan Mitra as an Additional Independent Director.

Artemis Medicare Services Ltd's board recommended a final dividend of Re. 0.45 per equity share (45%) for FY26, subject to shareholder approval at the upcoming AGM. The dividend will be paid within 30 days of the AGM's conclusion. The board also approved the audited financial results for the year ended March 31, 2026, appointed Mr. Tapan Mitra as an Additional Independent Director, and proposed the appointment of Dr. Girdhar J. Gyani as an Independent Director and the re-appointment of M/s. T R Chadha & Co LLP as Statutory Auditors, all subject to shareholder approval. Additionally, the board approved an 18-month extension for utilizing unutilized preferential issue funds.

Artemis Medicare Services Ltd has appointed Mr. Tapan Mitra as an Additional Director in the capacity of an Independent Director for a period of 3 years, effective from May 8, 2026, subject to shareholder approval. The board also approved the audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹0.45 per equity share. Additionally, the company seeks shareholder approval for the appointment of Dr. Girdhar J. Gyani as an Independent Director and the re-appointment of M/s. T R Chadha & Co LLP as Statutory Auditors.

Artemis Medicare Services Ltd's consolidated revenue from operations increased by 16.4% YoY in Q4 FY26 and 15.4% for the full year FY26. The company's EBITDA grew by 23.1% in Q4 and 18.0% for FY26, while net profit increased by 32.1% in Q4 and 26.2% for FY26. Artemis Hospital Gurgaon's revenue from operations was up by 18.8% in Q4 and 17.8% for FY26. The company is progressing with its Raipur facility expansion.